HUE048899T2 - Eljárás buprenorfin intermedierek elõállítására - Google Patents

Eljárás buprenorfin intermedierek elõállítására

Info

Publication number
HUE048899T2
HUE048899T2 HUE17199667A HUE17199667A HUE048899T2 HU E048899 T2 HUE048899 T2 HU E048899T2 HU E17199667 A HUE17199667 A HU E17199667A HU E17199667 A HUE17199667 A HU E17199667A HU E048899 T2 HUE048899 T2 HU E048899T2
Authority
HU
Hungary
Prior art keywords
intermediates
preparing buprenorphine
buprenorphine
preparing
buprenorphine intermediates
Prior art date
Application number
HUE17199667A
Other languages
English (en)
Inventor
Nicolas Archer
Michael Bease
Barbara Jamieson
Robert Marmor
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of HUE048899T2 publication Critical patent/HUE048899T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE17199667A 2011-10-03 2012-10-01 Eljárás buprenorfin intermedierek elõállítására HUE048899T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161542491P 2011-10-03 2011-10-03

Publications (1)

Publication Number Publication Date
HUE048899T2 true HUE048899T2 (hu) 2020-08-28

Family

ID=47046640

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE12775287A HUE040284T2 (hu) 2011-10-03 2012-10-01 Eljárás buprenorfin elõállítására
HUE17199667A HUE048899T2 (hu) 2011-10-03 2012-10-01 Eljárás buprenorfin intermedierek elõállítására

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE12775287A HUE040284T2 (hu) 2011-10-03 2012-10-01 Eljárás buprenorfin elõállítására

Country Status (11)

Country Link
US (2) US9624231B2 (hu)
EP (2) EP3321269B1 (hu)
AU (1) AU2012320291B2 (hu)
CA (2) CA3026884C (hu)
ES (2) ES2805655T3 (hu)
GB (2) GB2560284B (hu)
HU (2) HUE040284T2 (hu)
IN (1) IN2014CN03197A (hu)
PT (2) PT2763996T (hu)
WO (1) WO2013050748A2 (hu)
ZA (1) ZA201402624B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201814982T4 (en) 2013-06-11 2018-11-21 Rusan Pharma Ltd INDUSTRIAL PROCESS FOR THE PREPARATION OF BUPRENORPHINE AND ITS INTERMEDIATE PRODUCTS
US9701688B2 (en) 2014-05-05 2017-07-11 Noramco, Inc. Process for the preparation of opioid compounds
US9701687B2 (en) * 2014-05-05 2017-07-11 Noramco, Inc. Process for the preparation of opioid compounds
CA3001689A1 (en) * 2015-10-12 2017-04-20 Noramco, Inc. Process for the preparation of (s)-2-((4r,4as,6r,7r,7ar,12bs)-7,9-dimethoxy-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinolin-6-yl)-3,3-dimethylbutan-2-ol
SG11201803268TA (en) * 2015-10-26 2018-05-30 Orphomed Inc Ethylene glycol ether of buprenorphine
SK592017A3 (sk) 2017-07-04 2019-01-08 Saneca Pharmaceuticals A. S. Spôsob prípravy morfínanových zlúčenín
GB2591302A (en) 2020-01-27 2021-07-28 Azad Pharma Ag Process for the synthesis of buprenorphine
CN113956263B (zh) * 2021-12-06 2023-06-20 四川大学 一种吗啡衍生物丁丙诺啡的合成方法
WO2023111125A1 (en) 2021-12-16 2023-06-22 Arevipharma Gmbh Method of making buprenorphine and precursor compounds thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
FR2554816B1 (fr) * 1983-11-16 1986-09-26 Sanofi Sa Nouveau derive de la nororipavine presentant a la fois une activite agoniste et antagoniste des recepteurs morphiniques
KR100204659B1 (ko) * 1996-05-28 1999-06-15 강재헌 신규한 부프레노핀계 진통제용 화합물
JP2010510326A (ja) 2006-11-22 2010-04-02 プロジェニックス ファーマスーティカルス インコーポレーテッド 4,5−エポキシ−モルフィナニウム類似体のn−オキシド類
US8962841B2 (en) 2007-06-29 2015-02-24 Brock University Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids
US7928234B2 (en) * 2007-06-29 2011-04-19 Brock University Conversion of thebaine to morphine derivatives
WO2009067275A1 (en) * 2007-11-21 2009-05-28 Progenics Pharmaceuticals, Inc N-oxides of 4,5-epoxy-morphinanium analogs
JP2011516464A (ja) 2008-03-31 2011-05-26 サン・ファーマシューティカル・インダストリーズ・リミテッド モルフィナン類似体の改良された調製方法
WO2009132313A2 (en) * 2008-04-25 2009-10-29 Progenics Pharmaceuticals, Inc. Morphinan derivatives of organic and inorganic acids
PL2344509T3 (pl) * 2008-09-30 2016-04-29 SpecGx LLC Sposoby wytwarzania buprenorfiny przy zmniejszonym tworzeniu zanieczyszczeń
EP2344507B2 (en) * 2008-09-30 2021-05-26 Mallinckrodt LLC Processes for increasing the yield of the hydrolysis of the 3-o-methyl and 17-n-nitrile group in the preparation of opiate alkaloid derivatives
GB201111775D0 (en) * 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof

Also Published As

Publication number Publication date
AU2012320291B2 (en) 2015-06-18
GB2560284A (en) 2018-09-05
CA3026884A1 (en) 2013-04-11
GB2509659A (en) 2014-07-09
CA3026884C (en) 2020-10-27
CA2849988A1 (en) 2013-04-11
GB201407259D0 (en) 2014-06-11
GB2560284B (en) 2019-01-09
EP2763996A2 (en) 2014-08-13
EP2763996B1 (en) 2018-07-25
EP3321269B1 (en) 2020-04-29
HUE040284T2 (hu) 2019-02-28
US20140235860A1 (en) 2014-08-21
WO2013050748A3 (en) 2013-11-07
PT2763996T (pt) 2018-11-09
GB2560284A8 (en) 2018-10-10
GB2509659B (en) 2019-01-09
US9624231B2 (en) 2017-04-18
PT3321269T (pt) 2020-07-24
US10208054B2 (en) 2019-02-19
WO2013050748A2 (en) 2013-04-11
EP3321269A1 (en) 2018-05-16
ES2692885T3 (es) 2018-12-05
GB201810013D0 (en) 2018-08-01
ES2805655T3 (es) 2021-02-15
US20170217978A1 (en) 2017-08-03
IN2014CN03197A (hu) 2015-07-03
ZA201402624B (en) 2017-05-31
AU2012320291A1 (en) 2014-04-17
CA2849988C (en) 2019-09-10

Similar Documents

Publication Publication Date Title
EP2744336A4 (en) METHOD AND INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF MACROLACTAMEN
EP2699534A4 (en) PROCESS FOR PRODUCING TRANS-1233zd
GB201111595D0 (en) Improved process
GB201103499D0 (en) Process
GB201107072D0 (en) Process
PT2751073T (pt) Processo para a preparação de isocianatos
HUE048899T2 (hu) Eljárás buprenorfin intermedierek elõállítására
IL227872A0 (en) A process for the preparation of n-converted phenylhydroxylamines
GB201101370D0 (en) Process
EP2734627A4 (en) METHODS FOR INCREASING PRODUCT OUTPUTS
PL2753620T3 (pl) Nowy sposób otrzymywania fosamilu ceftaroliny
IL235420A (en) Process for making rebroxban by using intermediates
GB201112051D0 (en) Process
GB201107073D0 (en) Process
EP2740719A4 (en) PROCESS FOR THE PREPARATION OF A-FLUOROALDEHYDE
GB2488894B (en) Process for producing V-Coelenterazine compounds
EP2624693A4 (en) PROCESS FOR THE PREPARATION OF TOLVAPTAN INTERMEDIATES
GB201119957D0 (en) Process
PL2681199T3 (pl) Sposób wytwarzania (-)-hupercyny A
GB201115218D0 (en) Novel process
EP2662376A4 (en) PROCESS FOR THE PRODUCTION OF TORISEL
GB201103092D0 (en) Process
GB201105537D0 (en) New process
GB201112370D0 (en) Process
GB201116252D0 (en) Novel process